We are monitoring the impact of COVID-19 on MEA Contrast Media Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa Contrast Media Market Research Report - Segmented By Medical Procedure, Route of Administration, Type, Indication, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3293
Pages: 145

MEA Contrast Media Market Size (2022 to 2027)

As per the research report, the Middle East and Africa Contrast Media Market size have been estimated at USD 0.37 Billion in 2022. It is further estimated to grow at a CAGR of 1.08% and worth USD 0.39 billion by 2027. The Middle East and Africa Contrast Media market are growing at a slow rate.

An increase in the incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and other illnesses is expected to drive the contrast medical market in the MEA region. Contrast is utilized to increase and enhance the quality of pictures, and it is also used to distinguish between normal and pathological situations in some cases. The need for computed tomography (CT), magnetic resonance imaging (MRI), ultrasound imaging, and other diagnostic techniques has increased as a result.

Furthermore, the increasing prevalence of cardiovascular diseases, due to the rise in the population to the growing population of older people in the region, is estimated to fuel the market’s growth rate. In addition, the rising awareness about early diagnosis and its benefits among people are expected to influence market growth positively. 

Also, due to the increase in the demand for the syringeless power injectors and the presence of various types of contrast media and the applications such as automated patient data collection with low prices are driving the market growth of the contrast media. Moreover, increasing initiatives and investment from the government and non-government firms for the research processes, increasing new developments and advancements in the technology for enhancing the methodologies expand the market growth. 

However, the increase in the high cost of advanced therapies and treatment with the issues related to some side effects with symptoms such as vomiting, swelling, hives, and other contract reactions and damages due to which people hesitate to get treated; these are the factors that are limiting the growth of the market. Also, the approval processes related to the product with stringent government rules and regulation makes the product launch more tedious and challenging, as well as due to lack of skilled and trained professionals that are required for handling such advanced equipment and the diagnosing imaging systems are the other factors that are affecting the market growth of the contrast media.

This research report on the Middle East and Africa contrast media market has been segmented and sub-segmented into the following categories:

By Medical Procedure:         

  • X-Ray/CT  
  • MRI            
  • Ultrasound              

By Route of Administration:

  • Injectable Contrasts Media             
  • Oral Contrasts Media         
  • Rectal Contrasts Media     
  • Urethral Contrasts Media

By Type:

  • Iodinated
  • Gadolinium-Based
  • Microbubble
  • Barium- Based

By Indications: 

  • Cardiovascular Disorders
  • Oncology
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Musculoskeletal Disorders    

By Application: 

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East and Africa have an untapped market, and key players are slowly expanding to this region, which is the main reason for the market's growth in this region.

The UAE contrast media market dominated the MEA market in 2020, and it is estimated to show high growth in the market in the coming years. The significant increase is attributed to the standardized cardiovascular diseases mortality rates when compared to other regions. Its rate is 201 and 309 fatalities per 100,000 people.

The South African contrast media market is also expected to show a lucrative growth rate during the forecast period. The increasing competition between the market players and by adopting new advancements and developments in the technology, growing adoption of minimally invasive surgical techniques are driving the market growth of contrast media.

The Saudi Arabian contrast media market is projected to account for a promising share in the MEA contrast media market during the forecast period. The market growth is fuelled by the rising awareness, increasing initiatives, and investment from government and non-government firms for early diagnosis and improving the method for better imaging concentrations.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the MEA contrast media market profiled in the report are CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy) in 2015. Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), and Subhra Pharma Private Limited (India).

1.Introduction          

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases        

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary  

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints      

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Medical Procedure    

                                5.1.1 Introduction                                           

                                5.1.2 X-Ray/CT                                  

                                5.1.3 MRI                                            

                                5.1.4 Ultrasound

                                5.1.5  Y-o-Y Growth Analysis, By Medical Procedure                                        

                                5.1.6  Market Attractiveness Analysis, By Medical Procedure                                      

                                5.1.7  Market Share Analysis, By Medical Procedure                                        

                5.2 Route of Administration         

                                5.2.1 Introduction                                           

                                5.2.2 Injectable Contrasts Media

                                5.2.3 Oral Contrasts Media                                          

                                5.2.4 Rectal Contrasts Media                                      

                                5.2.5 Urethral Contrasts Media                                 

                                5.2.6 Y-o-Y Growth Analysis, By Route of Administration                                               

                                5.2.7 Market Attractiveness Analysis, By Route of Administration                                             

                                5.2.8 Market Share Analysis, By Route of Administration                                              

                5.3 Type      

                                5.3.1 Introduction                                           

                                5.3.2 Iodinated Contrasts Media                                              

                                5.3.3 Gadolinium-Based Contrasts Media                                             

                                5.3.4 Microbubble Contrasts Media                                        

                                5.3.5 Barium- Based Contrasts Media                                     

                                5.3.6 Y-o-Y Growth Analysis, By Type                                     

                                5.3.7  Market Attractiveness Analysis, By Type                                  

                                5.3.8  Market Share Analysis, By Type                                    

                5.4  Indications   

                                5.4.1 Introduction                                           

                                5.4.2 Cardiovascular Disorders                                   

                                5.4.3 Oncology                                 

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Gastrointestinal Disorders                                

                                5.4.6 Nephrological Disorders                                    

                                5.4.7 Musculoskeletal Disorders 

                                5.4.8 Y-o-Y Growth Analysis, By  Indications                                        

                                5.4.9  Market Attractiveness Analysis, By  Indications                                     

                                5.4.10  Market Share Analysis, By  Indications                                     

                5.5 Application   

                                5.5.1 Introduction                                           

                                5.5.2 Radiology                                 

                                5.5.3 Interventional Cardiology                                 

                                5.5.4 Interventional Radiology                                   

                                5.5.5 Y-o-Y Growth Analysis, By  Application                                        

                                5.5.6  Market Attractiveness Analysis, By Application                                      

                                5.5.7  Market Share Analysis, By Application                                       

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Medical Procedure                    

  6.1.3.3 By Route of Administration                          

  6.1.3.4 By Type                 

  6.1.3.5 By Indication                       

  6.1.3.6 By Application                    

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Medical Procedure                    

  6.1.4.3 By Route of Administration                          

  6.1.4.4 By Type                 

  6.1.4.5 By Indication                       

  6.1.4.6 By Application                    

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Medical Procedure                    

  6.1.5.3 By Route of Administration                          

  6.1.5.4 By Type                 

  6.1.5.5 By Indication                       

  6.1.5.6 By Application                    

                6.2 Middle-East        

                6.3 Africa    

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                 

                8.1 GE Healthcare   

                                8.1.1 Overview                                 

                                8.1.2 Medical Procedure Analysis                                             

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Spago Nanomedical AB 

                8.3 Subhra Pharma Private Limited  

                8.4 Daiichi Sankyo   

                8.5 CMC Contrast AB       

                8.6 Nanopet Pharma GmbH         

                8.7 Guerbet Group

                8.8 Bracco Imaging S.P.A      

                8.9 Bayer AG       

                8.10 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)     

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables  

                b) List of Figures      

 

  1. Middle East and Africa Contrast Media Market, By Procedure, From 2022 - 2027 (USD Million)
  2. Middle East and Africa X-ray/Computed Tomography (CT) Market, By Region, From 2022 - 2027 (USD Million)
  3. Middle East and Africa Magnetic Resonance Imaging (MRI) Market, By Region, From 2022 - 2027 (USD Million)
  4. Middle East and Africa Ultrasound Market, By Region, From 2022 - 2027 (USD Million)
  5. Middle East and Africa Contrast Media Market, By Route of Administration, From 2022 - 2027 (USD Million)
  6. Middle East and Africa Oral Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  7. Middle East and Africa Injectable Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  8. Middle East and Africa Rectal Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  9. Middle East and Africa Urethral Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  10. Middle East and Africa Contrast Media Market, By Type, From 2022 - 2027 (USD Million)
  11. Middle East and Africa Barium-Based Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  12. Middle East and Africa Iodinated Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  13. Middle East and Africa Gadolinium-Based Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  14. Middle East and Africa Microbubble Contrast Media Market, By Region, From 2022 - 2027 (USD Million)
  15. Middle East and Africa Contrast Media Market, By Indication, From 2022 - 2027 (USD Million)
  16. Middle East and Africa Cardiovascular Disorders Market, By Region, From 2022 - 2027 (USD Million)
  17. Middle East and Africa Oncology Market, By Region, From 2022 - 2027 (USD Million)
  18. Middle East and Africa Gastrointestinal Disorders Market, By Region, From 2022 - 2027 (USD Million)
  19. Middle East and Africa Musculoskeletal Disorders Market, By Region, From 2022 - 2027 (USD Million)
  20. Middle East and Africa Neurological Disorders Market, By Region, From 2022 - 2027 (USD Million)
  21. Middle East and Africa Nephrological Disorders Market, By Region, From 2022 - 2027 (USD Million)
  22. Middle East and Africa Contrast Media Market, By Application, From 2022 - 2027 (USD Million)
  23. Middle East and Africa Radiology Market, By Region, From 2022 - 2027 (USD Million)
  24. Middle East and Africa Interventional Radiology Market, By Region, From 2022 - 2027 (USD Million)
  25. Middle East and Africa Interventional Cardiology Market, By Region, From 2022 - 2027 (USD Million)
  26. Middle East Contrast Media Market, By Procedure, From 2022 - 2027 (USD Million)
  27. Middle East Contrast Media Market, By Route of Administration, From 2022 - 2027 (USD Million)
  28. Middle East Contrast Media Market, By Type, From 2022 - 2027 (USD Million)
  29. Middle East Contrast Media Market, By Indication, From 2022 - 2027 (USD Million)
  30. Middle East Contrast Media Market, By Application, From 2022 - 2027 (USD Million)
  31. Africa Contrast Media Market, By Procedure, From 2022 - 2027 (USD Million)
  32. Africa Contrast Media Market, By Route of Administration, From 2022 - 2027 (USD Million)
  33. Africa Contrast Media Market, By Type, From 2022 - 2027 (USD Million)
  34. Africa Contrast Media Market, By Indication, From 2022 - 2027 (USD Million)
  35. Africa Contrast Media Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample